1. News | 2022.07.01

   Monitoring and early warning: Pasteur Center in Cameroon plays an active role in the response to SARS-CoV-2 virus

   As a first-line laboratory in the event of a health emergency, the Pasteur Center in Cameroon was naturally designated as a COVID-19 reference laboratory by the Cameroon health authorities in 2020. How did the Pasteur Center in Cameroon organize its response to this emerging novel virus at national level throughout the epidemic, and how is it monitoring the virus today?At the beginning of the...

2. Document de presse | 2023.11.14

   Significant "post-COVID" resurgence in invasive meningococcal disease

   A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by...

3. News | 2020.04.28

   International Network of Pasteur Institutes: deepening the scientific collective strategy

   Three years ago, the scientific community of the Institut Pasteur International Network  (IPIN) expressed its desire to build a comprehensive strategy in order to strengthen its positioning and establish itself as a global public health authority. The Scientific Steering Committee of the Institut Pasteur International Network(COS-RIIP) was created in August 2019 to help achieve this goal....

4. News | 2020.12.01

   Use of the maladiecoronavirus.fr web application during the first wave helped reduce call volumes to the French medical emergency number

   The maladiecoronavirus.fr web application is a self-triage tool for suspected COVID-19 cases. It was the first application to be approved by the French Ministry of Health in March 2020, and has since been used by almost 13 million people. A study has demonstrated that use of maladiecoronavirus.fr led to an eightfold reduction in the number of unnecessary calls to the French medical emergency...

5. Document de presse | 2024.02.22

   New epidemiological surveillance indicators for more effective monitoring of suicide attempts

   Teams from the Child and Adolescent Psychiatry Department at Robert Debré Hospital (AP-HP), the AP-HP Digital Services Department and the Institut Pasteur, coordinated by Romain Bey and Prof. Richard Delorme, have developed novel digital tools to improve mental health monitoring for people living in the Greater Paris region. The data in this retrospective study were generated by analyzing several...

6. Document de presse | 2024.05.28

   AFROSCREEN: a key network for genomic surveillance in Sub-Saharan Africa

   Three years after its launch, AFROSCREEN meets all its objectives, developing effective genomic surveillance to tackle epidemics  in sub-Saharan Africa The AFROSCREEN project, financed to the tune of €10 million by Agence Française de Développement (AFD), has been working since 2021 to set up or strengthen sequencing platforms and build an operational network for monitoring emerging...

7. Article | 2020.06.16

   Evolution of SARS-CoV-2 and the antibody immune response in humans during infection

   Aim: to understand the evolution of the SARS-CoV-2 viral population in hosts during illness, in relation with the infectivity of the virus and the establishment of the humoral (antibody-based) immune response. This knowledge is important to identify trends in disease progression and help improve the treatment and post-treatment follow-up given to patients. Detailed data on the evolution of...

8. News | 2021.09.09

   SPKM001, a promising anti-SARS-CoV-2 monoclonal antibody, is being developed by the Institut Pasteur and SpikImm

   Following encouraging initial results, which will be published shortly, the Institut Pasteur and SpikImm announce the development of the antibody SPKM001.Paris, September 9, 2021SPKM001 is a high affinity human monoclonal antibody which targets the receptor-binding site (RBD) on the Spike protein of the original SARS-CoV-2 strain and its variants.Initial preclinical results tend to show that this...

9. News | 2022.01.12

   French Prime Minister Jean Castex salutes the Institut Pasteur's expertise on emerging infectious diseases

   French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on Monday January 10, 2022, to salute the efforts of scientists in the ongoing battle against COVID-19. The visit was an opportunity to highlight the need to strengthen preparedness for future emerging diseases. It was also an auspicious moment...

10. Document de presse | 2023.03.31

    The Institut Pasteur and the University of São Paulo sign articles of association to establish the Institut Pasteur in São Paulo

    On Friday March 31st, 2023 at a ceremony in Paris, the Institut Pasteur President, Professor Stewart Cole, and the University of São Paulo (USP) Rector, Carlos Gilberto Carlotti Junior, signed articles of association for the Institut Pasteur in São Paulo, a private non-profit organization under Brazilian law. The mission of the institute, an associate member of the Pasteur Network, is to conduct...

Pages